Synergy Mechanism
Upstream hormonal + direct arousal.
PT-141 (Bremelanotide) (melanocortin receptor agonist (mc3r/mc4r) that acts centrally in the hypothalamus to stimulate sexual arousal independent of vascular mechanisms.) and Kisspeptin (hypothalamic neuropeptide that activates gnrh neurons to stimulate lh/fsh release, regulating reproductive function and libido.) work through complementary pathways, producing a synergistic effect greater than either compound alone.
Combined Dosing Protocol
| Compound | Dose | Frequency | WADA |
|---|---|---|---|
| PT-141 (Bremelanotide) | 1mg - 2mg | As needed, 45 minutes before activity | |
| Kisspeptin | 1nmol/kg - 10nmol/kg | Pulsatile or as per fertility protocol |
Get This Protocol
Hatter Labs provides physician-supervised PT-141 (Bremelanotide) + Kisspeptin stack protocols with GMP-certified compounds.
Get ProtocolStart Your Performance Protocol for PT-141 (Bremelanotide) + Kisspeptin Stack
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised